Digital Sponsored The hardest part of becoming an AI-first company: It’s not t... Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.
Market Access Beyond Market Access: Why healthcare-system understanding is... Healthcare-system literacy, and the ability to contribute to system shaping, must become part of how healthcare leaders make decisions.
Sales & Marketing The hidden risks of biotech layoffs: Why cost-cutting trigge... Reducing your team without a strategic risk plan actually spikes corporate vulnerability more than it lowers burn rates.
Sales & Marketing The new healthcare playbook: Turning workflow into revenue Healthcare organisations aren’t struggling because they lack growth strategies, they’re struggling because they can’t operationalise them.
Sales & Marketing A philosophical look at market turn in the Age of AI, with J... John Holodnak, co-founder of Occam, discusses how AI is beginning to reshape career paths across life sciences.
Digital The evolution of leadership for healthcare organisations in ... Leaders must be adaptive, forward-thinking, and equipped to cultivate environments where humans and AI work together effectively and ethically.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.